Plasmapheresis in a patient with "refractory" urticarial vasculitis

Allergy, Asthma and Immunology Research

Volumn 4, Issue 4, 2012, Pages 245-247

  Kartal, Ozgur ^a   Gulec, Mustafa ^a   Caliskaner, Zafer ^a   Nevruz, Oral ^a   Cetin, Turker ^a   Sener, Osman ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Plasmapheresis; Treatment; Urticarial vasculitis

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DESLORATADINE; FIBRINOGEN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ABDOMINAL PAIN; ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; EXTRAVASATION; FEMALE; FEVER; HUMAN; HYPERPIGMENTATION; IMMUNOFLUORESCENCE TEST; KERATOPATHY; NEUTROPHIL CHEMOTAXIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRICK TEST; PRURITUS; QUALITY OF LIFE; REFRACTORY URTICARIAL VASCULITIS; SKIN BIOPSY; SKIN BURNING SENSATION; SKIN SWELLING; TREATMENT RESPONSE; URTICARIA; VASCULITIS;

EID: 84863859984     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2012.4.4.245     Document Type: Article

References (11)

1. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328:1599-604.
2. Platzer MH, Grattan CE, Poulsen LK, Skov PS. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients. Allergy 2005;60:1152-6.
3. Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 2004;24:183-213, vi.
4. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B. Dermatology Section of the European Academy of Allergology and Clinical Immu-nology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64:1427-43.
5. Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992; 339:1078-80.
6. Jiang X, Lu M, Ying Y, Feng J, Ye Y. A case report of double-filtration plasmapheresis for the resolution of refractory chronic urticaria. Ther Apher Dial 2008;12:505-8.
7. Alexander JL, Kalaaji AN, Shehan JM, Yokel BK, Pittelkow MR. Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia. J Drugs Dermatol 2006;5: 534-7.
8. Jones RR, Bhogal B, Dash A, Schifferli J. Urticaria and vasculitis: a continuum of histological and immunopathological changes. Br J Dermatol 1983;108:695-703.
9. Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 2005;9:391-5.
10. Owen HG, Brecher ME. Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion 1994;34:891-4.
11. De Luca G, Lugaresi A, Iarlori C, Marzoli F, Di Iorio A, Gambi D, Uncini A. Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1999;95:190-4.